North Macedonia - Pharmaceutical products - Procurement of medicines for 2026 Biological therapy

01

This tender covers the procurement of medicines for biological therapy for 2026. The products to be supplied are bevacizumab biosimilar 400 mg/16 ml and capivasertib 200 mg, classified under the pharmaceutical products scope for North Macedonia. The supplies are intended for the delivery of biological therapy medicines for the 2026 programme.

02

Description

03

University clinic of radiotherapy and oncology

North Macedonia

notices in the register

13

This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - North Macedonia

Based on 4 awards with a linked company profile over the last 2 years.

13 open tenders right now

• North Macedonia - Medical consumables - Procurement of medical supplies No deadline published
• North Macedonia - Repair and maintenance services of medical and precision equipment - Full service (regular maintenance and interventional servicing) for therapy machines No deadline published
• North Macedonia - Pharmaceutical products - Laboratory reagents and materials No deadline published

04

Market context

TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it cannot be placed among the open notices of its sector. The official documents may state one.

open now in Medical equipment & pharmaceuticals

10,824

median open notice

€144,479